Akanda Corp. Acquires Holigen Limited from The Flowr Corporation

Hempsana Holdings Ltd. Completes Acquisition of Hempsana Inc.

July 12, 2021

Pharmaceuticals

Hempsana Holdings Ltd. (formerly Stralak Resource Inc.) completed a previously announced three‑cornered amalgamation to acquire Hempsana Inc., making Hempsana a wholly‑owned subsidiary. The combined company will focus on manufacturing cannabis derivatives and extracts (including vapeables, topicals and infused consumables) from Hempsana's Health Canada standard processing licensed and EU‑GMP‑compliant facility; HHL's shares are expected to trade on the Canadian Securities Exchange under the ticker HMPS.

GrowerIQ Acquires Ample Organics from Akerna

January 15, 2024

Software

Toronto-based GrowerIQ has acquired fellow cannabis software provider Ample Organics from U.S.-based Akerna in an all-cash deal that closed in December; financial terms were not disclosed. The acquisition brings Ample's seven employees onto GrowerIQ's ~25-person team and combines two seed-to-sale ERP platforms to create what GrowerIQ calls the largest cannabis tech platform in Canada (and a stronger position in Europe).

PharmaForceIQ Acquires Aktana

January 9, 2026

Cloud & SaaS

PharmaForceIQ has acquired Aktana in an asset acquisition to integrate Aktana's AI-driven field Next-Best-Action platform into PharmaForceIQ's digital orchestration offering. The deal is intended to create an end-to-end 'optichannel-in-a-box' commercial engagement solution for life sciences, deepen PharmaForceIQ's U.S. footprint and expand reach across LATAM, APAC and EMEA; Canaccord Genuity acted as sole financial advisor.

HempFusion Acquires Apothecanna

May 17, 2021

Consumer Products

HempFusion Wellness Inc. has acquired 100% of APCNA Holdings LLC (Apothecanna) for initial consideration of US$15.0 million, with up to US$10.0 million in additional milestone payments tied to revenue targets. The deal expands HempFusion's retail distribution (adding ~1,800 stores including CVS), bolsters its e-commerce presence, and is immediately accretive based on Apothecanna's ~US$3.8–4.0 million 2020 revenue.

Curaleaf Holdings Acquires Northern Green Canada

March 19, 2024

Pharmaceuticals

Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.

Fulgent Genetics Acquires Fulgent Pharma

November 7, 2022

Biotechnology

Fulgent Genetics completed the acquisition of Fulgent Pharma Holdings for approximately $100 million in a combination of cash and Fulgent common stock. The deal integrates Fulgent Pharma’s nanoencapsulation drug-delivery platform and clinical-stage oncology pipeline with Fulgent Genetics’ diagnostics capabilities to create a vertically integrated precision-medicine offering focused on cancer.